Key result
Immediate surgery (≤6 hours) in ACS patients with elevated troponins was associated with high in-hospital mortality and MACCE, which decreased with delayed surgery.
Why the study?
Admission cardiac troponin I and T and timing to surgery have been suggested as independent predictors of adverse outcomes in patients with ACS undergoing CABG, but their combined predictive value required multicenter evaluation.
Do preoperative cardiac troponin levels and timing to surgery predict adverse outcomes in patients with ACS undergoing CABG?
Cohort (n=3,114)
Yes
Do preoperative cardiac troponin levels and timing to surgery predict adverse outcomes in patients with ACS undergoing CABG?
In patients with ACS undergoing CABG, high preoperative troponin levels and immediate surgery are associated with worse outcomes, suggesting that delaying surgery may be beneficial if hemodynamics are stable.
Answers are grounded in this paper and cite their sources.
Preoperative troponin and timing independently predict IHM/MACCE after ACS-CABG; leaves open optimal thresholds for randomized confirmation.
BACKGROUND: Cardiac troponin (cTn) I and T on admission as well as timing to surgery have been suggested as independent predictors for adverse outcomes in patients with acute coronary syndromes (ACS) undergoing coronary artery bypass grafting (CABG). We therefore sought to evaluate the association and predictive value of timing to surgery together with preoperative cTnI and T on a multicenter basis. METHODS: A total of 3114 patients with ACS who underwent CABG between January 2010 and March 2023 were prospectively entered into a multicentric registry. Key end points were in-hospital mortality (IHM) and major adverse cardiac and cerebrovascular events (MACCE). RESULTS: CTnI or T levels were increased on admission between survivors and nonsurvivors (6.0 vs 16.6 ng/mL, P < .001; and 0.8 vs 1.2 ng/mL, P < .001). Timing between symptom onset and CABG was within ≤6 hours in 5.6% of patients, >6 to ≤24 hours in 18.4%, >24 to ≤72 hours in 32.2%, and >72 hours in 43.8%. IHM and MACCE were highest for patients operated on within ≤6 hours (20.6% and 39.2%) but decreased with increase in timing (P < .001). Multivariable logistic regression analysis revealed preoperative cTnI and time to surgery as strong and independent predictors of IHM and MACCE. Higher cTnI levels were associated with decreased survival and lower freedom from MACCE with immediate surgery but inversely increased with delayed time to surgery. CONCLUSIONS: High preoperative cTnI or T levels associated with immediate surgery are closely related to unfavorable outcomes in patients undergoing bypass surgery for ACS. Patients with elevated troponin levels may benefit from delaying surgery, as long as the patient's hemodynamics remain stable.
No takes yet. Share an insight, caveat, or question.
Thielmann et al. (2025) conducted a cohort in Acute coronary syndromes (ACS) undergoing coronary artery bypass grafting (CABG) (n=3,114). Timing to surgery and preoperative cardiac troponin levels vs. Delayed surgery and lower troponin levels was evaluated on In-hospital mortality (IHM) and major adverse cardiac and cerebrovascular events (MACCE) (p=<.001). Immediate surgery (≤6 hours) in ACS patients with elevated troponins was associated with high in-hospital mortality and MACCE, which decreased with delayed surgery.
Synapse has enriched 10 related papers. Consider them for comparative context: